HIV ‐associated nephropathy: A decade of clinical outcomes, global disparities and emerging promise
HIV Medicine · 2026-11 · 27 (11) · 1753-1762
DOI: 10.1111/hiv.70315 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift HIV Medicine, online erschienen am 29.09.2026. Verfasst von Deepak V Pathiyil und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: AIDS-Associated Nephropathy, HIV Infections. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Cambridge, National Institute for Health and Care Research.
Abstract (Originalsprache)
Objective
To review the pathogenesis, epidemiology, clinical presentation, management and outcomes of HIV‐associated nephropathy (HIVAN), with emphasis on global disparities, genetic susceptibility ( APOL1 ) and emerging therapeutic and technological advances.
Design
Narrative literature review synthesizing contemporary evidence from clinical cohorts, translational research and guideline‐based practice, with comparative perspectives from high‐resource (UK) and low‐resource (sub‐Saharan Africa) settings.
Methods
Relevant studies were analysed to evaluate mechanisms of disease, epidemiological trends, diagnostic approaches, treatment strategies and long‐term outcomes. Particular focus was placed on APOL1 ‐associated risk, antiretroviral therapy (ART) impact and recent developments including artificial intelligence (AI) applications and targeted therapies.
Results
HIVAN arises from direct HIV infection of renal epithelial cells in genetically susceptible individuals, particularly those with APOL1 risk variants. ART has significantly reduced incidence in high‐income settings, whereas HIVAN remains prevalent in sub‐Saharan Africa due to delayed diagnosis and limited healthcare access. Clinically, HIVAN presents with proteinuria and progressive kidney dysfunction, requiring biopsy for confirmation. Early ART initiation improves renal outcomes, supported by adjunctive therapies such as renin‐angiotensin system blockade and SGLT2 inhibitors. Emerging therapies targeting APOL1 and advances in AI‐driven risk prediction and diagnostics show promise.
Conclusions
HIVAN reflects an interplay between viral, genetic and socio‐economic factors. While ART has transformed outcomes in well‐resourced settings, significant global disparities persist. Future progress depends on improving HIV care access, expanding renal services and advancing precision medicine approaches, including APOL1 ‐targeted therapies and AI‐enabled risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Cambridge, Cambridge, UK.
- Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
- University of Cape Town, Cape Town, South Africa.
- National Health Laboratory Service (NHLS), University of Cape Town, Cape Town, South Africa.
- Kings College London, London, UK.
- Kings College Hospital NHS Foundation Trust, London, UK.
ORCID-Profile: Deepak V Pathiyil, Brendon Price, Frank Post, Dami A Collier
Förderung
- University of Cambridge
- National Institute for Health and Care Research
Zitieren
APA
Pathiyil, D. V., Wearne, N., Price, B., Post, F., & Collier, D. A. (2026). HIV ‐associated nephropathy: A decade of clinical outcomes, global disparities and emerging promise. HIV Medicine, 27(11), 1753-1762. https://doi.org/10.1111/hiv.70315
Vancouver
Pathiyil DV, Wearne N, Price B, Post F, Collier DA. HIV ‐associated nephropathy: A decade of clinical outcomes, global disparities and emerging promise. HIV Medicine. 2026;27(11):1753-1762. doi:10.1111/hiv.70315
BibTeX
@article{Pathiyil2026,
author = {Pathiyil, Deepak V and Wearne, Nicola and Price, Brendon and Post, Frank and Collier, Dami A},
title = {HIV ‐associated nephropathy: A decade of clinical outcomes, global disparities and emerging promise},
journal = {HIV Medicine},
year = {2026},
volume = {27},
number = {11},
pages = {1753--1762},
doi = {10.1111/hiv.70315}
}
EUVIMED